209 related articles for article (PubMed ID: 11060809)
1. Transplantation therapy for Parkinson's disease.
Borlongan CV
Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
[TBL] [Abstract][Full Text] [Related]
2. Bilateral intracaudate cografting of fetal ventral mesencephalon and striatum in advanced Parkinson's disease.
Kudoh C; Detta A; Meyer C; Byrne P; Hitchcock E
Transplant Proc; 1999 Dec; 31(8):3397-402. PubMed ID: 10616520
[No Abstract] [Full Text] [Related]
3. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
Subrt O; Tichy M; Vladyka V; Hurt K
Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
[TBL] [Abstract][Full Text] [Related]
4. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?
Liu J; Huang HY
Neurosci Bull; 2007 Nov; 23(6):377-82. PubMed ID: 18064069
[TBL] [Abstract][Full Text] [Related]
5. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
Kirik D; Björklund A
Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
[No Abstract] [Full Text] [Related]
6. Clinical application of neuronal grafts in Parkinson's disease.
Lindvall O
J Neurol; 1994 Dec; 242(1 Suppl 1):S54-6. PubMed ID: 7699411
[TBL] [Abstract][Full Text] [Related]
7. Cellular replacement therapy for Parkinson's disease--where we are today?
Redmond DE
Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
[TBL] [Abstract][Full Text] [Related]
8. Clinical neurotransplantation protocol for Huntington's and Parkinson's disease.
Lopez WO; Nikkhah G; Kahlert UD; Maciaczyk D; Bogiel T; Moellers S; Schültke E; Döbrössy M; Maciaczyk J
Restor Neurol Neurosci; 2013; 31(5):579-95. PubMed ID: 23777636
[TBL] [Abstract][Full Text] [Related]
9. A comparative evaluation of clinical rating scales and quantitative measurements in assessment pre and post striatal implantation of human foetal mesencephalon in Parkinson's disease.
Henderson BT; Kenny BG; Hitchcock ER; Hughes RC; Clough CG
Acta Neurochir Suppl (Wien); 1991; 52():48-50. PubMed ID: 1792966
[TBL] [Abstract][Full Text] [Related]
10. Transplants in Parkinson's disease.
Lindvall O
Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic implantation of fetal mesencephalon.
Hitchcock ER; Kenny BG; Clough CG; Hughes RC; Henderson BT; Detta A
Stereotact Funct Neurosurg; 1990; 54-55():282-9. PubMed ID: 2080343
[TBL] [Abstract][Full Text] [Related]
13. CNS immunological modulation of neural graft rejection and survival.
Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
[TBL] [Abstract][Full Text] [Related]
14. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
[No Abstract] [Full Text] [Related]
15. Immature neural tissue grafts in Parkinson's disease.
Widner H
Acta Neurol Scand Suppl; 1993; 146():43-5. PubMed ID: 8333253
[TBL] [Abstract][Full Text] [Related]
16. Neural transplantation for the treatment of Parkinson's disease.
Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
[No Abstract] [Full Text] [Related]
17. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
18. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson's disease.
Bhattacharya N; Chhetri MK; Mukherjee KL; Ghosh AB; Samanta BK; Mitra R; Bhattacharya M; Bhattacharya S; Bandopadhyaya T
Clin Exp Obstet Gynecol; 2002; 29(4):259-66. PubMed ID: 12635741
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Piccini P; Pavese N; Hagell P; Reimer J; Björklund A; Oertel WH; Quinn NP; Brooks DJ; Lindvall O
Brain; 2005 Dec; 128(Pt 12):2977-86. PubMed ID: 16246865
[TBL] [Abstract][Full Text] [Related]
20. Update on fetal transplantation: the Swedish experience.
Lindvall O
Mov Disord; 1998; 13 Suppl 1():83-7. PubMed ID: 9613723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
